Rankings
▼
Calendar
VCEL Q1 2023 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$41M
+13.7% YoY
Gross Profit
$27M
64.7% margin
Operating Income
-$8M
-19.9% margin
Net Income
-$7M
-18.3% margin
EPS (Diluted)
$-0.13
QoQ Revenue Growth
-22.2%
Cash Flow
Operating Cash Flow
$8M
Free Cash Flow
-$1M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$265M
Total Liabilities
$71M
Stockholders' Equity
$194M
Cash & Equivalents
$62M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$41M
$36M
+13.7%
Gross Profit
$27M
$23M
+13.1%
Operating Income
-$8M
-$7M
-12.4%
Net Income
-$7M
-$7M
-5.7%
Revenue Segments
MACI Implants And Kits
$34M
100%
← FY 2023
All Quarters
Q2 2023 →